All Stories

  1. Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699

    Article • Journal of Pharmacology and Experimental Therapeutics, October 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Zheng Yang